Insights

Personalized epilepsy care EnlitenAI offers a device-agnostic platform (Neuroliten) for remote monitoring and titration of epilepsy treatment, indicating a strong value proposition for hospitals and health systems looking to optimize seizure management and reduce titration delays.

Digital health awards Recent quarterfinalist recognitions in Rising Star and Digital Health Awards position EnlitenAI as a credible innovator, a talking point to engage health plans, hospital partners, and grant programs seeking proven digital health vendors.

Cloud-native tech The tech stack leveraging AWS Lambda, DynamoDB, Next.js and Python suggests scalable, cloud-based deployment with potential for integration into existing hospital IT ecosystems and data analytics pipelines.

Funding and pilots Initial funding from Advanced Industries grant and a revenue range of 1M-10M, plus collaboration with UCHealth on cloud platform studies, create opening for expansion opportunities, strategic pilots, and co-development with health networks.

Expansion potential Long-term vision to broaden Neuroliten to other neurological and behavioral conditions signals cross-market opportunity for neuro clinics, telemedicine providers, and integrated care networks seeking scalable, device-agnostic monitoring platforms.

EnlitenAI, Inc Tech Stack

EnlitenAI, Inc uses 8 technology products and services including html5media, AWS Lambda, Amazon Web Services, and more. Explore EnlitenAI, Inc's tech stack below.

  • html5media
    Audio, Video, Graphics
  • AWS Lambda
    Big Data Processing
  • Amazon Web Services
    Cloud Hosting
  • Amazon S3
    Content Delivery Network
  • Amazon DynamoDB
    Database
  • React
    Javascript Frameworks
  • iOS
    Programming Languages
  • Nginx
    Web Servers

EnlitenAI, Inc's Email Address Formats

EnlitenAI, Inc uses at least 1 format(s):
EnlitenAI, Inc Email FormatsExamplePercentage
First@enlitenai.comJohn@enlitenai.com
75%
First.Last@enlitenai.comJohn.Doe@enlitenai.com
25%

Frequently Asked Questions

What is EnlitenAI, Inc's official website and social media links?

Minus sign iconPlus sign icon
EnlitenAI, Inc's official website is enlitenai.com and has social profiles on LinkedInCrunchbase.

How much revenue does EnlitenAI, Inc generate?

Minus sign iconPlus sign icon
As of August 2026, EnlitenAI, Inc's annual revenue is estimated to be $1M - $10M.

What is EnlitenAI, Inc's NAICS code?

Minus sign iconPlus sign icon
EnlitenAI, Inc's NAICS code is 62 - Health Care and Social Assistance.

How many employees does EnlitenAI, Inc have currently?

Minus sign iconPlus sign icon
As of August 2026, EnlitenAI, Inc has approximately 8 employees across 2 continents, including North AmericaAsia. Key team members include Chief Executive Officer, Founder: H. M.. Explore EnlitenAI, Inc's employee directory with LeadIQ.

What industry does EnlitenAI, Inc belong to?

Minus sign iconPlus sign icon
EnlitenAI, Inc operates in the Hospitals and Health Care industry.

What technology does EnlitenAI, Inc use?

Minus sign iconPlus sign icon
EnlitenAI, Inc's tech stack includes html5mediaAWS LambdaAmazon Web ServicesAmazon S3Amazon DynamoDBReactiOSNginx.

What is EnlitenAI, Inc's email format?

Minus sign iconPlus sign icon
EnlitenAI, Inc's email format typically follows the pattern of First@enlitenai.com. Find more EnlitenAI, Inc email formats with LeadIQ.

How much funding has EnlitenAI, Inc raised to date?

Minus sign iconPlus sign icon
As of August 2026, EnlitenAI, Inc has raised $605K in funding. The last funding round occurred on May 01, 2023 for $150K.

When was EnlitenAI, Inc founded?

Minus sign iconPlus sign icon
EnlitenAI, Inc was founded in 2021.
EnlitenAI, Inc logo

EnlitenAI, Inc

Hospitals and Health CareCalifornia, United States2-10 Employees

EnlitenAI, Inc is a healthcare company based in Tracy, California, focused on managing epilepsy through a device-agnostic platform called Neuroliten that leverages wearable devices for remote monitoring and treatment titration. The platform supports seizure burden calculations to inform decisions about dose adjustments or drug substitutions, aiming to reduce delays in care and shorten titration cycles. In later stages, it is planned to add features for drug and dose recommendations to address the trial-and-error aspect of epilepsy management, with a long-term goal of extending Neuroliten to other neurological and behavioral conditions. The company operates within the hospitals and health care industry, positioning itself to serve clinicians and patients seeking more efficient, data-informed epilepsy management from a remote monitoring workflow. EnlitenAI is active in the San Francisco Bay Area ecosystem and has been recognized in industry forums for digital health and home health diagnostics and monitoring.

Section iconCompany Overview

NAICS Code
62 - Health Care and Social Assistance
Founded
2021
Employees
2-10

Section iconFunding & Financials

  • $605K

    EnlitenAI, Inc has raised a total of $605K of funding over 3 rounds. Their latest funding round was raised on May 01, 2023 in the amount of $150Kas a pre_seed.

  • $1M - $10M

    EnlitenAI, Inc's revenue is estimated to be in the range of $1M - $10M

Section iconFunding & Financials

  • $605K

    EnlitenAI, Inc has raised a total of $605K of funding over 3 rounds. Their latest funding round was raised on May 01, 2023 in the amount of $150Kas a pre_seed.

  • $1M - $10M

    EnlitenAI, Inc's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.